公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1996 | Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein | Hwang L.-H.; PEI-MING YANG ; Lai M.-Y.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; Wang, Jin-Town ; Lee S.-Y.; Chian H.-M.; Chi W.-K.; Chu Y.-D.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 13 | 12 | |
2009 | IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients | Chuang J.Y.; Yang S.S.; Lu Y.T.; Hsieh Y.Y.; Chen C.Y.; SHAN-CHWEN CHANG ; Chang C.S.; Yeh H.Z.; JIA-HORNG KAO | Digestive and Liver Disease | 35 | 29 | |
2013 | IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Liu W.-L.; CHI-LING CHEN ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 10 | 8 | |
2011 | Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations | Ochi H.; Maekawa T.; Abe H.; Hayashida Y.; Nakano R.; Imamura M.; Hiraga N.; Kawakami Y.; Aimitsu S.; JIA-HORNG KAO ; Tsunoda M.K.; Tsunoda T.; Kumada H.; Nakamura Y.; Hayes N.C.; Chayama K. | Journal of General Virology | 51 | 42 | |
2013 | IL28B genotype on HCV infection in Asia | CHEN-HUA LIU ; JIA-HORNG KAO | Current Hepatitis Reports | 3 | 0 | |
1994 | Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection | Tsai S.-L.; PEI-JER CHEN ; Hwang L.-H.; JIA-HORNG KAO ; Huang J.-H.; Chang T.-H.; Chen D.-S. | Journal of Hepatology | 29 | 30 | |
1993 | Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications | PEI-JER CHEN ; Hwang L.-H.; Chang L.-Y.; JIA-HORNG KAO ; Chen D.-S. | Gastroenterologia Japonica | 0 | 1 | |
1997 | Immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 2 | |
2022 | The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan | Lin C.-L.; Tai C.-M.; Huang J.-F.; CHUN-JEN LIU ; Chen H.-F.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Wang C.-C.; Weng S.-H.; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 2 | 2 | |
2023 | The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease | Tsai, Pei-Shan; Cheng, Yu-Ming; Wang, Chia-Chi; JIA-HORNG KAO | European journal of gastroenterology & hepatology | 1 | 0 | |
2021 | The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma | Wang C.-C.; Tseng K.-C.; Tzeng I.-S.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 7 | 6 | |
2023 | Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease | Cheng, Yu-Ming; Hsieh, Tsung-Han; Wang, Chia-Chi; JIA-HORNG KAO | JHEP reports : innovation in hepatology | 0 | 1 | |
2012 | Impact of hepatitis B virus infection on metabolic profiles and modifying factors | Hsu C.-S.; CHEN-HUA LIU ; Wang C.-C.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 60 | 54 | |
2007 | Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; JIA-HORNG KAO ; SUI-YUAN CHANG ; Chen M.-Y.; SZU-MIN HSIEH ; PEI-JER CHEN ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 73 | 60 | |
2017 | Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up | Chen H.-Y.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 12 | 9 | |
2022 | Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR) | Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; SHIH-JER HSU ; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. | Clinical Gastroenterology and Hepatology | 14 | 12 | |
2010 | Implications of hepatitis B virus genomic variations on treatment outcomes | TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Current Pharmacogenomics and Personalized Medicine | 5 | 0 | |
2020 | Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection | CHIH-YANG HSIAO ; Teng X.; TUNG-HUNG SU ; PO-HUANG LEE ; JIA-HORNG KAO ; KAI-WEN HUANG | Clinics and Research in Hepatology and Gastroenterology | 5 | 6 | |
2021 | Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling | CHIH-YANG HSIAO ; Teng, Xiao; TUNG-HUNG SU ; PO-HUANG LEE ; JIA-HORNG KAO ; KAI-WEN HUANG | Quantitative Imaging in Medicine and Surgery | 4 | 4 | |
2015 | Improving clinical outcomes of chronic hepatitis B virus infection | TUNG-HUNG SU ; JIA-HORNG KAO | Expert review of Gastroenterology and Hepatology | 26 | 23 |